CP
ABBV icon

Canopy Partners’s AbbVie ABBV Stock Holding History

Canopy Partners’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.36M Buy
5,423
+14
+0.3% +$3.01K 0.41% 52
2026
Q1 		$1.18M Buy
5,409
+29
+0.5% +$6.43K 0.4% 50
2025
Q4 		$1.23M Hold
5,380
– – 0.4% 51
2025
Q3 		$1.25M Buy
5,380
+120
+2% +$24.4K 0.42% 52
2025
Q2 		$976K Sell
5,260
-419
-7% -$77.9K 0.36% 63
2025
Q1 		$1.19M Sell
5,679
-153
-3% -$29.7K 0.46% 47
2024
Q4 		$1.04M Buy
5,832
+1,476
+34% +$271K 0.4% 55
2024
Q3 		$860K Buy
4,356
+59
+1% +$11K 0.37% 62
2024
Q2 		$737K Sell
4,297
-11
-0.3% -$1.82K 0.34% 68
2024
Q1 		$784K Buy
4,308
+614
+17% +$106K 0.38% 60
2023
Q4 		$572K Buy
+3,694
New +$539K 0.35% 69

Other funds holding ABBV

LMFP
Larry Mathis Financial Planning Phoenix, Arizona $124B AUM
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
ATO
Alecta Tjanstepension Omsesidigt Stockholm, Sweden $23.8B AUM 34.25% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
HCM
Hamlin Capital Management New York $4.45B AUM 22.95% 1-Year Est. Return
AAMU
AEGON Asset Management (UK) Edinburgh, United Kingdom $9.38B AUM 48.94% 1-Year Est. Return
FWCM
Ferguson Wellman Capital Management Portland, Oregon $8.19B AUM 30.56% 1-Year Est. Return

Canopy Partners's ABBV Position: Q2 2026 in Review

Canopy Partners increased its AbbVie (ABBV) stake by 0.26% in Q2 2026, buying an estimated $3.01K and bringing the position to 5,423 shares worth $1.36M. The position accounts for 0.41% of the portfolio, ranked #52.

Canopy Partners first reported a position in ABBV in Q4 2023 and has held it in 11 quarters since. 1,416 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Canopy Partners held 5,423 shares of AbbVie worth $1.36M as of Q2 2026.
  • Canopy Partners bought 14 AbbVie shares in Q2 2026, an estimated $3.01K.
  • AbbVie made up 0.41% of Canopy Partners's portfolio in Q2 2026, its #52 holding.
  • Canopy Partners first reported a position in AbbVie in Q4 2023 and has held it in 11 quarters since.
  • 1,416 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Canopy Partners's 13F filing for Q2 2026, filed 22 Jul 2026.